Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
about
NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammationAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyGroup II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonistsSelective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerThe therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseN-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.Nociception modulation by supraspinal group III metabotropic glutamate receptors.A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.Extracellular N-acetylaspartylglutamate released in the nucleus accumbens modulates the pain sensation: Analysis using a microdialysis/mass spectrometry integrated system.Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation
P2860
Q30459203-154CFB3B-43E3-42F0-8D91-967D2037EE03Q30465259-F3B6615E-17E5-4150-8E65-AAEA164AA320Q30466262-D41D3D17-8300-433E-9CDE-39373D15C962Q34293335-244F90A9-B0B5-42EF-ACB4-5FC3D4662F36Q34537679-8DDF90D0-4B97-4F8A-9934-D191126026E0Q35685315-E7D14C26-8622-4774-911D-966C48B89B4EQ37861794-B1F6F4AA-C72E-442B-90D2-0B2008A20B8CQ37972920-579BF3E4-3328-494B-B82F-60FAF8BE56AEQ38831232-9AC7A903-FF09-423B-9253-8519E0690F0CQ38833017-82190524-01D7-495B-93BE-D1F88FD46C2BQ38882060-1B4A5495-7BD0-4654-AADC-025539B658F2Q38887993-39F03EB0-4487-4DF6-AC76-6C819579E014Q42065018-FDB758C5-6D51-4151-8C6A-CF9ED09B352FQ50135884-322AA2BB-EA26-4274-B862-75A08D2AC270Q57816814-A40E7614-1419-4008-BBA4-6471A766ADA2
P2860
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Intracerebroventricular admini ...... nalgesic in inflammatory pain.
@en
Intracerebroventricular administration of N-acetylaspartylglutamate
@nl
type
label
Intracerebroventricular admini ...... nalgesic in inflammatory pain.
@en
Intracerebroventricular administration of N-acetylaspartylglutamate
@nl
prefLabel
Intracerebroventricular admini ...... nalgesic in inflammatory pain.
@en
Intracerebroventricular administration of N-acetylaspartylglutamate
@nl
P2093
P2860
P356
P1433
P1476
Intracerebroventricular admini ...... nalgesic in inflammatory pain.
@en
P2093
Alan Kozikowski
Joseph H Neale
Tatsuo Yamamoto
P2860
P2888
P356
10.1186/1744-8069-4-31
P577
2008-08-01T00:00:00Z
P5875
P6179
1023752140